Qinecsa

qinecsa.com · Londonderry County Borough, United Kingdom

Qinecsa is a pharmacovigilance and drug safety services provider that supports pharmaceutical and biotech companies with end‑to‑end safety operations, including case processing, signal management, medical review, and regulatory reporting. It combines specialized safety operations teams with proprietary technology platforms to help clients manage global safety data and comply with regulatory requirements across the product lifecycle. The company generates revenue through outsourced safety services and technology-enabled safety solutions delivered on a contract basis.

Revenue
$50M - $250M
Employees
201 - 1,000
Founded
2021
Headquarters
Londonderry County Borough, United Kingdom

Qinecsa customers on Arbolus

Total customers 10 10 current · 0 former
Reviews growth 6 new reviews since Jun 2026

Customers who reviewed Qinecsa

Seniority of Qinecsa customers

Most people who reviewed Qinecsa hold Director roles (80%), followed by C-Suite (10%) and Manager (10%).

  • Director 80%
  • C-Suite 10%
  • Manager 10%

Customers sample

Revenue Leader Director NPS 9
Operations Leader Director NPS 7 Undecided
Strategy Leader Director NPS 9 Will renew

Employer names and spend open in the full report, along with the other 7 customers.

What 10 Arbolus experts think of Qinecsa

Overall sentiment: Positive

NPS scores for Qinecsa are weighted toward promoters, with over 70% sharing scores of 8 or above; a minority are neutral or unsure. 60% of experts express explicit renewal intent while others remain open or cautious, especially those piloting the platform. Stickiness is highest among mid- to large-sized enterprises and organizations with expansive compliance needs. Key positive themes are regulatory expertise, reliability, and operational efficiency, while caution centers on advanced AI features and global scalability.

Everything 10 customers told us about Qinecsa.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

20 Net Promoter Score, from 10 scored reviews
  • Promoters 4
  • Passives 4
  • Detractors 2

Praised

  • Modernized User Experience
  • AI Automation for End-to-End Workflows
  • Growth in Compliance-Focused Segments
  • Specialized Regulatory and PV Expertise

Criticised

  • UI and Customization Gaps
  • Limited Advanced AI Integration
  • Scalability for Large Pharma
  • Compliance or Quality Failures

What Qinecsa customers say

Specialized Regulatory and PV Expertise

“I have confidence in Qinecsa’s regulatory and pharmacovigilance expertise, which supports our global compliance and ensures consistent audit readiness.”

Strategy Leader · Information Technology · 10,000+ employees · APAC

Operational Flexibility and Fast Onboarding

“I value the agility and flexibility of this vendor, as their implementation process is much faster and more responsive than larger, traditional providers.”

Operations Leader · Health Care · 10,000+ employees · EMEA

Comprehensive Suite Covering All Safety Needs

“I rely on Qinecsa’s broad platform that streamlines everything from case management to regulatory compliance while supporting scalability for growth.”

Other Leader · Health Care · 10,000+ employees · North America

Renewal intent

Plan to renew 56%
  • Will renew 5
  • Undecided 3
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 1 answer
  • Director 71% 7 answers
  • Manager 0% 1 answer
  • 8.8/10 Average score from customers who will renew
  • 6.3/10 Average score from undecided customers
  • 0/10 Average score from customers not renewing

Top alternatives

Most weighed by Qinecsa customers

Report

Nov 2026 10 + 0

For people who use Qinecsa

Do you use Qinecsa at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 10 customers of Qinecsa have already contributed

Takes a few minutes. Your identity stays anonymous.